Clinical Trial Update: MELD ESAS Evolution: Assessment of the Symptomatic Burden of Patients With Advanced Chronic Liver Disease

View source ↗

Summary

The MELD ESAS Evolution study, evaluating the symptomatic burden in patients with advanced chronic liver disease, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Liver Disease
• Liver Disease

Snippet

Sponsor: Unidade Local de Saúde de Matosinhos, EPE | Conditions: Palliative Care, End Stage Liver DIsease | Status: COMPLETED